2,141
Views
0
CrossRef citations to date
0
Altmetric
Articles

Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions

ORCID Icon, , , , , , , , , , , , , , , , , , , , , & show all
Pages 76-90 | Received 30 Mar 2022, Accepted 14 Jul 2022, Published online: 13 Aug 2022

References

  • Julg B, Dee L, Ananworanich J, et al. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting. Lancet HIV. 2019;6(4):e259–e268.
  • Li JZ, Smith DM, Mellors JW. The need for treatment interruption studies and biomarker identification in the search for an HIV cure. AIDS. 2015;29(12):1429–1432.
  • Giron L, Papasavvas E, Yin X, et al. Phospholipid metabolism is associated with time to HIV rebound upon treatment interruption. MBio. 2021;12(1):e03444-20.
  • Giron L, Palmer C, Liu Q, et al. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021;12(1):3922.
  • Garner SA, Rennie S, Ananworanich J, et al. Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations. J Virus Erad. 2017;3(2):82–84.
  • Dubé K, Auerbach JD, Stirratt MJ, Gaist P. Applying the behavioural and social sciences research (BSSR) functional framework to HIV cure research. J Int AIDS Soc. 2019;22(10):e25404.
  • Tasso. [cited 28 Aug 2021]. Available: https://www.tassoinc.com/
  • Dubé K, Evans D, Dee L, et al. We need to deploy them very thoughtfully and carefully: perceptions of analytical treatment interruptions in HIV cure. AIDS Res Hum Retrovirus. 2018;34(1):67–79.
  • Medina-Marino A, de Vos L, Bezuidenhout D, et al. I got tested at home, the help came to me: acceptability and feasibility of home-based TB testing of household contacts using portable molecular diagnostics in South Africa. Trop Med Int Health. 2021;26(3):343–354.
  • Armstrong-Hough M, Ggita J, Turimumahoro P, et al. Something so hard: a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda. Int J Tuberc Lung Dis. 2018;22(10):1152–1159.
  • Gupta-Wright A, Manabe YC. Implementation science: point-of-care diagnostics in HIV and tuberculosis. Clin Med (Lond). 2019;19(2):145–148.
  • Sudharsanan N, Chen S, Garber M, Bärnighausen T, Geldsetzer P. The effect of home-based hypertension screening on blood pressure change over time in South Africa. Health Aff (Millwood). 2020;39(1):124–132.
  • Fuller G, Njune Mouapi K, Joung S, et al. Feasibility of patient-centric remote dried blood sampling: the prediction, risk, and evaluation of major adverse cardiac events (PRE-MACE) study. Biodemogr Soc Biol. 2020;65(4):313–322.
  • Clarke S, Foster J. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93.
  • Melendez J, Hamill M, Armington G, Gaydos C, Manabe Y. Home-based testing for sexually transmitted infections: leveraging online resources during the COVID-19 pandemic. Sex Transm Dis. 2021;48(1):e8–e10.
  • Anderson C, Breithaupt L, Des Marais A, et al. Acceptability and ease of use of mailed HPV self-collection among infrequently screened women in North Carolina. Sex Transm Infect. 2018;94(2):131–137.
  • Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.
  • Fajardo-Bernal L, Aponte-Gonzalez J, Vigil P, et al. Home-based versus clinic-based specimen collection in the management of chlamydia trachomatis and Neisseria gonorrhoeae infections. Cochrane Database Syst Rev. 2015;2015(9):CD011317.
  • Lunny C, Taylor D, Hoang L, et al. Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis. PLoS One. 2015;10(7):e0132776-23.
  • Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of Human papillomavirus self testing in female adolescents. Sex Transm Infect. 2005;81(5):408–414.
  • Huppert JS, Hesse EA, Bernard MA, et al. Acceptability of self-testing for trichomoniasis increases with experience. Sex Transm Infect. 2011;87(6):494–500.
  • Tiro JA, Betts AC, Kimbel K, et al. Understanding patients’ perspectives and information needs following a positive home human papillomavirus self-sampling kit result. J Womens Health (Larchmt). 2019;28(3):384–392.
  • Pearson WS, Kreisel K, Peterman TA, et al. Improving STD service delivery: would american patients and providers use self-tests for gonorrhea and chlamydia? Prev Med. 2018;115:26–30.
  • Sultana F, Mullins R, English DR, et al. Women’s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015;15(1):1–10.
  • Colfax G, Lehman J, Bindman A, et al. What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care. 2002;14(5):675–626.
  • Figueroa C, Johnson C, Ford N, et al. Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis. Lancet HIV. 2018;5(6):e277–e90.
  • Figueroa C, Johnson C, Verster A, Baggaley R. Attitudes and acceptability on HIV self-testing among key populations: a literature review. AIDS Behav. 2015;19(11):1949–1965.
  • Tucker JD, Wei C, Pendse R, Lo Y-R. HIV self-testing among key populations: an implementation science approach to evaluating self-testing. J Virus Erad. 2015;1(1):38–42.
  • Mugo C, Wang J, Begnel ER, et al. Home- and clinic-based pediatric HIV index case testing in Kenya: uptake, HIV prevalence, linkage to care, and missed opportunities. J Acquir Immune Defic Syndr. 2020;85(5):535–542.
  • Ibitoye M, Lappen H, Freeman R, Jordan AE, Aronson ID. Technology-based interventions to increase point-of-care HIV testing and linkage to care among youth in the US: a systematic review. AIDS Behav. 2021;25(6):1829–1838.
  • Merchant RC, Clark MA, Liu T, et al. Comparison of home-based oral fluid rapid HIV self-testing versus mail-in blood sample collection or medical/community HIV testing by young adult Black, Hispanic, and White MSM: results from a randomized trial. AIDS Behav. 2018;22(1):337–346.
  • Siegler AJ, Mayer KH, Liu AY, et al. Developing and assessing the feasibility of a home-based preexposure prophylaxis monitoring and support program. Clin Infect Dis. 2019;68(3):501–504.
  • Lau JSY, Smith MZ, Allan B, et al. Perspectives on analytical treatment interruptions in people living with HIV and their health care providers in the landscape of HIV cure-focused studies. AIDS Res Hum Retrovirus. 2019;2:1–8.
  • Dubé K, Kanazawa J, Roebuck C, et al. We are looking at the future right now: community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States. HIV Res Clin Pract. 2022;1–16. Online ahead of print.
  • Dubé K, Eskaf S, Hastie E, et al. Preliminary acceptability of a home-based peripheral blood collection device for viral load testing in the context of analytical treatment interruptions in HIV cure trials: results from a nationwide survey in the United States. J Pers Med. 2022;12:1–21.
  • Cresswell J. Research Design. Qualitative, Quantitative, and Mixed Methods Approaches. 4th ed. Thousand Oaks, CA: Sage Publications; 2013.
  • Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
  • Peluso MJ, Dee L, Shao S, et al. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-Cov-2 pandemic: a collaborative approach. Clin Infect Dis. 2021;72(10):1843–1849. doi: 10.1093/cid/ciaa1260.
  • Bhatti P, Kampa D, Alexander BH, et al. Blood spots as an alternative to whole blood collection and the effect of a small monetary incentive to increase participation in genetic association studies. BMC Med Res Methodol. 2009;9:76–76.
  • Rockett JC, Buck GM, Lynch CD, Perreault SD. The value of home-based collection of biospecimens in reproductive epidemiology. Environ Health Perspect. 2004;112(1):94–104.
  • Solheim SA, Ringsted TK, Nordsborg NB, Dehnes Y, Levernaes MCS, Mørkeberg J. No pain, just gain: painless, easy, and fast dried blood spot collection from fingertip and upper arm in doping control. Drug Test Anal. 2021;13(10):1783–1790.
  • Hendelman T, Chaudhary A, LeClair AC, et al. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One. 2021;16(9):e0255841–9.